Ongoing clinical trials of anti-platelet agents in the management of acute ischaemic coronary syndromes

Author： Straznicky I.T.   Zambanini A.   White H.D.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.7, Iss.5, 1998-05, pp. : 811-822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of antiplatelet therapy in the management of acute coronary syndromes

By Volturo Gregory A   Mazzola Jennifer L   Przylenk Karin  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 541-556

Informa Healthcare

Access to resources Recommend Favorite

Recent Antiplatelet Drug Trials in the Acute Coronary Syndromes: Clinical Interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT

By Alexander J.H.   Harrington R.A.  

Drugs, Vol. 56, Iss. 6, 1998-12 ,pp. : 965-976

Adis International

Access to resources Recommend Favorite

Antiplatelet therapy in acute coronary syndromes

By Menozzi Alberto   Lina Daniela   Conte Giulio   Mantovani Francesco   Ardissino Diego  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 27-42

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet therapy in acute coronary syndromes

By Natarajan Arun   Tarique Ahmar   Zaman Azfar G  

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 388-391

Royal College Of Physicians

Access to resources Recommend Favorite

Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

By Jennings Lisa K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 727-737

Informa Healthcare

Access to resources Recommend Favorite